chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a Nurse Practitioner concerning a 24 year old female patient who on 27-JUN-2007 was vaccinated IM in the left deltoid with the first dose of GARDASIL (Lot #657737/0522U).  Concomitant therapy included hormonal contraceptives (unspecified).  On 27-JUN-2007 the patient experienced constant burning and tenderness at injection site on her left arm.  She also reported that movement of the arm made it worse and was more painful at the end of the day.  It was hard for the patient to flex her tricep muscles.  There was no swelling or redness.  On 01-AUG-2007, the patient returned to the office, and complained of continued burning and tenderness at the site of injection. There was no swelling, redness, or fever. The patient was treated with ibuprofen (WYETH).  As of 03-AUG-2007, the patient had not recovered.  Medical attention was sought.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 9/17/2007. At the time of this report, the outcome of the events was unknown. Additional information is not expected.
Right arm started to itch; Pain around the injection site; Feel sick; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Right arm started to itch), ILLNESS (Feel sick), FATIGUE (Tired) and VACCINATION SITE PAIN (Pain around the injection site) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Urinary tract disorder NOS. Concomitant products included LOSARTAN for Blood pressure abnormal, METHOCARBAMOL for Muscle relaxant, FAMOTIDINE for Stomach discomfort, OXYBUTYNIN for Urinary tract disorder NOS, ALBUTEROL [SALBUTAMOL] and OXYCODONE HYDROCHLORIDE (OXYCODON) for an unknown indication.    On 06-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced ILLNESS (Feel sick) and FATIGUE (Tired). On 15-Oct-2021, the patient experienced PRURITUS (Right arm started to itch) and VACCINATION SITE PAIN (Pain around the injection site). On 15-Oct-2021, ILLNESS (Feel sick) and FATIGUE (Tired) had resolved. At the time of the report, PRURITUS (Right arm started to itch) and VACCINATION SITE PAIN (Pain around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided.  Concomitant medication included Albuterol which was used as a bronchodilator and Oxycodon which was used as an analgesic.  Patient did not was fine for first few days.
swelling, lumps, bumps, and rash at injection sites and around mouth; swelling, lumps, bumps, and rash at injection sites and around mouth; swelling, lumps, bumps, and rash at injection sites and around mouth; swelling, lumps, bumps, and rash at injection sites and around mouth; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Juvéderm volbella xc, notes: injected in the nasolabial folds and vermillion border with x1 syringe. The following information was reported: VACCINATION SITE SWELLING (non-serious), VACCINATION SITE MASS (non-serious), VACCINATION SITE RASH (non-serious), ORAL MUCOSAL ERUPTION (non-serious), outcome "unknown" and all described as "swelling, lumps, bumps, and rash at injection sites and around mouth".  Additional information: Healthcare professional reported that a patient was injected in the nasolabial folds and vermillion border with x1 syringe of JUVÉDERM VOLBELLA® XC. Approximately five months later the patient noticed "swelling, lumps, bumps, and rash at injection sites and around mouth." HCP reported the patient received 1st injection of COVID (Pfizer) vaccine four months after injection.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe nausea and migraine type headache, OTC acetaminophen and ibuprofen not helping.
Medication did not inject properly in the arm. Patient received an unknown amount of the vaccine, but I believe it was at least less than half of the full dose.
My arm had the typical swelling and burning for the first shot and second.  I have not got my period since 8/24/21 my first dose, but I have had light spotting randomly. Today's date is 10/4.  My lips are swelling and peeling, I see that the side effects are that if you have filler. In addition, I was very sick after the first shot with a 102 fever for 48 hours. My muscles hurt and my entire body was achy!
Noticed L upper pain with 3" swelling, redness, heat, hardness.  5-12-09 Went to place @ 6-7 pm.-  was told "reaction to tetanus but not bad enough not to have tetanus in future."  They advised Benadryl 5-13-09 9am mom called office to report- less swelling redness less pain today.
This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-MAY-2016, the patient was vaccinated with improperly stored dose of ROTATEQ lot # L033545 with expiry date on 30-MAY-2017, oral (strength and dose were not reported). No product quality complaint was involved and no adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse concerning a patient with no past medical history who "about a month ago" approximately on 22-OCT-2006 was vaccinated with Pneumovax 23 (0.5 ml) (lot # 650541/1004P), intramuscularly. There was no concomitant medication. On approximately 23-OCT-2006 the patient experienced redness and soreness around the injection site. Unspecified medical attention was sought. Subsequently, the patient recovered. This report also involved two other patients, for a total of three, and it was reported that "two of the patients developed a fever."  Additional information has been requested.
Per patient's chart   She noted red area about 1" in diameter starting yesterday Pt given Varicella vaccination in (L) thigh 06/16/2020 - ten days ago Mom is certain there was no red area in the spot prior to yesterday Pt was playing outside yesterday, however, mom is certain pt did not get an insect bite. Mom describes as a hives several times before stating appearance may be more like a pimple Mom did gently squeeze to see if anything would come out Mom checked temp - pt is afebrile She is itching the area but is otherwise not overly bothered by it Pt is acting normally Mom is concerned red area may be an indication of allergy to varicella or reaction to vaccine  PEr note from urgent care Patient was diagnosed with chicken pox
Face became immediately hot; face became red; face became swollen; This is a spontaneous report from a contactable consumer, the patient, via COVID-19 Adverse Event Self-Reporting Solution.   A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6201), via an unspecified route of administration  in the left arm on 19Mar2021  at 10:00 (at the age of 66-years-old) as as single dose for COVID-19 immunisation.  Medical history included hypertension and chronic Lyme disease; both from unknown dates and unknown if ongoing.  The patient's concomitant medications were not reported.  On 19Mar2021 at 10:00, the patient's face became immediately hot, red and swollen.  Therapeutic measures were taken as a result of face became hot, red and swollen and included treatment with ice packs, diphenhydramine (BENADRYL) and unspecified steroids. The clinical outcome of the patient's face became immediately hot, red and swollen was not recovered.   No follow-up attempts are required. No further information is expected.
She had her vaccine and within 5 minutes her face became really tight, she cannot smile.  Then she is forgetting things as well, taking her a long time to process thoughts.  As time goes on the situation seems to be getting worse.  Her muscles seem to be weak in her face.  She has not called her doctor yet.
Under arm pain; very little swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 10 year-old female patient received bnt162b2 (BNT162B2), administration date 30Nov2021 (Batch/Lot number: unknown) at the age of 10 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1, Unknown manufacturer), for COVID-19 Immunization. The following information was reported: AXILLARY PAIN (non-serious) with onset 2021, outcome "unknown", described as "Under arm pain"; SWELLING (non-serious) with onset 2021, outcome "unknown", described as "very little swelling".  Optional Information: No other patient information. Twin sister received the same dose at same time no headache, and no bellyache.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Follow-up (05Jan2022)This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
At 4:45 PM child felt warm.  Mother did not take temperture.  At 8:15 or 8:20 PM child 's temperture 103.3.  Child started to have a seizure.  Ambulance called.  Child transported to Hospital.  Dr. was the attending doctor in the ER.  Child was unconscious for ten minutes.  Child had been given Pentacel and Prevnar at a child's clinic earlier in the day.  Mother said child never had a seizure  before or after any vaccines.  Mother instructed to call family doctor.  Mother called me at 3:15 PM 03-10-09.
mild flu; Initial information received on 08-Oct-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves unknown demographic patient who experienced mild flu (influenza), while he/she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number and Expiry date unknown) via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious mild flu (influenza) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was reported that spouse received Fluzone HD about 2 weeks ago. Caller reports no adverse reaction, but does express some concern about lack of protection against the second B flu strain (B/Phuket) not included in the Fluzone HD. Caller reports receiving Fluzone HD the past couple of years and having contracted a "mild flu for bout 2-3 days" while in the tropics during the winter.  Final diagnosis was mild flu.   It was not reported if the patient received a corrective treatment.  On an unknown date, the event outcome is reported as Recovered for mild flu.  Information on the batch number was requested.  List of documents held by sender: none.
Developed hives on rt upper arm that eventually spread across chest. Took BENADRYL with some relief. 4-8-13: Hives not present.
Patient reports nausea and left arm tingling. LBST checked on patient. Vitals taken BP 158/84, pulse 68.  Patient also reports headache, shakiness and reports he feels like his throat is closing up. LBST checked on patient again. bp is 152/80. Patient drank some water and took his hyoscyamine on his own ( patient wasn't directed to take this medication). Patient stayed about an extra 15-20 minutes after the initial 15 minute wait. Patient  Was feeling better when he left- symptoms resolved.
Information has been received through the pregnancy registry for GARDASIL from a medical assistant concerning a 26 year old female with erythromycin hypersensitivity who on 27-FEB-2007 was vaccinated with a dose of GARDASIL (Lot# 656372/0243U), 0.5 ml.  Concomitant therapy included NUVARING.  The patient received GARDASIL while being pregnant (LMP 05-FEB-2007).  Follow-up phone call information has been received from a nurse who reported that the patient delivered an 8 pound male, at 39 weeks EGA, with Apgars of 8 and 9.  Thick mecomium was noted after artificial rupture of membranes during labor.  The baby was healthy, normal and there were no complications.  No additional information is expected.
This is a spontaneous report from a contactable consumer. A 10-year-old female patient received PREVNAR 13 in her arm on 22Jan2011. The patient was also administered another unspecified vaccine in her leg that same day. There was no relevant past medical history and the patient did not have any concomitant medications. On 22Jan2011, following administration of the vaccines, the patient experienced severe pain in her arms. At the time of this report, the outcome of severe pain in her arms was unknown.
Itchy huge rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy huge rash) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OLANZAPINE (ZYPREXA), FLUOXETINE HYDROCHLORIDE (PROZAC), ARIPIPRAZOLE (ABILIFY) and CLONAZEPAM for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH PRURITIC (Itchy huge rash). At the time of the report, RASH PRURITIC (Itchy huge rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not receive any treatment for the reported adverse events.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: The patient stated that she was feeling fine and only experienced symptoms for couple of days. She did not want to do any further follow up.
mom PC stating pt acting strange,pt is weak & stares into space;advised to MD to er,28sep94 MD stated pts sxs caused by diarrhea that pt had had for 5 days; tx w/ atb;
Moderna covid-19 vaccine eua Fatigue, headache, chills, body aches, fever.
36-48 hours after dose given, T up to 100.4, 4" raised red/hot to touch lesion, hives on upper torso. Resolved with Benadryl. Occurred on 11/7/03. Did not seek medical attention. Flu vaccine received.
Fever 1 hr after vaccine, then two episodes diarrhea, vomiting x1, fatigue
The night I got the vaccine I was studying and all of a sudden I couldn?t finish my sentence and felt like I was going to pass out.  My eyes unfocused, I got slightly nauseous, I went absent, and my heart raced. I couldn?t focus the rest of the night I felt very off and strange. It was very sudden and scary. I shook for like 30 minutes after. It has been happening on and off in very short durations for four days now.
Moderna first dose 2/16/21 - Expected reaction - achiness, slightly elevated temp - lasted less than 24 hours; vaccine site sore for about a week; no other significant problems. Moderna second dose 3/16/21 - same as with first dose for first week.  About 10 days after second dose hallucinations (?); 5:00 am got up, dressed, and walked downstairs asking if I had called the police, because he said I had told him to get up and come downstairs so I could call them.  There were not problems needing the police.  We took it as a very real dream and he went back to bed.  Over the next few weeks, he experienced weakness and dizziness/vertigo  causing three falls.  Went to primary care physician who prescribed Antivert and is sending him for a CAT scan and to a neurologist for further evaluation (vestibuar neuritis?  labyrinthitis?).
3x3 cm redness/ warmth/ induration at vaccination site within 20 minutes relieved with ice pack and 10mg Zyrtec.
This spontaneous report as received from a medical assistant refers to a patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored PNEUMOVAX 23 Lot# L026033 with expiration date: 27-MAR-2017 and lot# L035882 with expiration date: 19-APR-2017 (dose and route of administration were not reported). Administered doses of PNEUMOVAX 23 underwent a temperature excursion at 9 degrees Celsius for 1 minute. There were no previous excursions. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
COVID arm; red; inflamed from shoulder to elbow; swelled up pretty bad; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE INFLAMMATION (inflamed from shoulder to elbow) and VACCINATION SITE SWELLING (swelled up pretty bad) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Cholesterol total abnormal NOS. Concomitant products included MELOXICAM for Pain management, CHOLESTEROL for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE INFLAMMATION (inflamed from shoulder to elbow) and VACCINATION SITE SWELLING (swelled up pretty bad). At the time of the report, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE INFLAMMATION (inflamed from shoulder to elbow) and VACCINATION SITE SWELLING (swelled up pretty bad) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications also included blood pressure medications. No treatment details were reported.   This case was linked to MOD-2021-402860, MOD-2021-402856 (Patient Link).   Reporter did not allow further contact
w/in hrs of receiving flu vax pt began shaking & exp vomiting w/a small amount of blood noted; following morning pt exp chest pain, SOB, paleness & clamminess; pt was hospitalized & died 15OCT91; COD congestive heart failure;
Received injection in the left deltoid. Had circumferential swelling with some erythema and warmth to touch of the left upper extremity extending from the shoulder/axilla to about 1 inch proximal to the wrist. Child complains of itchiness and mild pain. Asked mother to give ibuprofen and Benadryl to symptomatic treatment, as well as cold compress. Pt was followed up on 2 subsequent visits. Reports had to visit the ED one time due to vomiting and subjective fever, was reassured by ED as vaccine reaction. Patient last returned for follow up 5 days after vaccine injection, symptoms improved greatly but not yet resolved at that time.
Minimal swelling of her throat; A spontaneous report was received from a physician, concerning a female patient of unspecified age, who received Moderna's COVID-19 Vaccine and experienced minimal swelling of her throat.  The patient's medical history was not provided. Concomitant product use was not provided.  On 17-Jan-2021, prior to the onset of event, the patient received the first of two planned doses of mRNA-1273 (batch number 41620A) intramuscularly for COVID-19 infection prophylaxis.   On 17-Jan-2021, the patient complained of minimal swelling of her throat. The swelling got resolved in about an hour and there was no effect on respiration. The patient did not seek medical attention or treatment. Reporter denied consent to follow-up.  Action taken with mRNA-1273 in response to the event was not provided.  The event, minimal swelling of her throat, was considered resolved on 17-Jan-2021.; Reporter's Comments: This spontaneous report concerns a female patient who experienced an event of minimal swelling of her throat. The event occurred on the same day after the administration of the first dose of the vaccine mRNA-1273 vaccine (Lot #: 41620A, expiration date-Unknown).  No treatment was administered and the event resolved 1 hour later.  Based on the information provided, which includes a strong temporal association between the reported event of minimal swelling of her throat and the administration of mRNA-1273 vaccine,  a causal association cannot be excluded.
inconsolable bouts of crying for 1 wk p/receiving vax reported to MD 19DEC95;
Hair loss, Eye Problems and no energy.    Tried hair treatment, had side effects and had to stop using.   Went to eye doctors, had my reading glasses changes (Stigmatism got worse.)  And still having problems with my eyes.    Note about the hair loss.  I had been noticing hair loss, didn't realize it was a side effect until talking to my son.  He had hair loss  after having Covid and was asking me about it.  And I decided to search hair loss and found out that there was a study referencing this. And people that didn't have covid. Then I searched hair loss after vaccines, for those that didn't have covid. And there was  a number of people that had hair loss and when I read about their problems, then I realized I had the same thing.
Swelling and red with spots and Itching.  Becoming worse each day. started 4 to 5 days after injection.
Left arm has been hurting and pain gotten worse. Inability to move the left arm from shoulder area. Primary doctor requested for a therapy and xray to be carried out and prescribed muscle relaxant and non steroid pain killers
Lymph nodes were swollen; This is a spontaneous report from a contactable consumer (Patient). A 55-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration in Feb2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCIN, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation. On an unspecified date in 2021, after the second shot, patient lymph nodes were swollen. It was reported that patient was scheduled an appointment for a yearly mammogram 8 weeks after the 2nd shot, they confirmed that her lymph nodes were swollen and stated that was probably from the COVID shot. Patient was informed to come back for follow-up 2 months later and it's been 4 months since 2nd COVID shot and lymph nodes are still swollen. The event was reported as non-serious. The outcome of the event was not recovered.  Information about Lot/Batch number has been requested.
After about 5 minutes patient started to feel dizzy, light headed and nauseous. After a few more minutes she started to have a headache and chest paints.  Her face was flushed and sweaty. She was transferred by EMS to the hospital.
Pt developed 6x6 cm red hot rash localized to site of varicella injection administered on 8/11/11. Rash is mildly erythematous on exam dated 8/15/11. This has resolved w/o tx. Location (R) thigh at site of SQ injection.